Dave Singh discusses alarmins and COPD biologics in HCPLive interview
HCPLive posted on X about an interview with Dave Singh, MD, asking whether biologics for COPD are moving beyond eosinophils and who is likely to respond.
“Are COPD biologics moving beyond eosinophils?”— HCPLive
HCPLive, the clinical news outlet, posted on X on 7 November 2026 about its latest interview with Dave Singh, MD. The post opened with a question: whether COPD biologics are moving beyond eosinophils.
According to HCPLive, Singh "talks alarmins" in the interview. The outlet described the "big question for pulmonologists" as who will respond to these treatments.
The post did not set out what Singh said, and it gave no data, trial names or conclusions from the conversation. The interview itself is available through a link in the post.
HCPLive also pointed readers to its wider coverage tagged #GOLD2026, which it linked in the same post. The post gave no further detail on that coverage.
Original source
“Are COPD biologics moving beyond eosinophils?”
— HCPLive View the post on X
